Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysisSilvia Belloni, Cristina Arrigoni, Paola Tiberio et al.|Critical Reviews in Oncology/Hematology|2024Cited by 5
Italian Validation of the Healthcare Needs Scale for Youth with Congenital Heart Disease and Its Short-Form DevelopmentFederica Dellafiore, Rosario Caruso, Francesco Pittella et al.|Congenital Heart Disease|2020Cited by 3
Fingerprint change as a consequence of anticancer treatments: A systematic integrative reviewSilvia Belloni, Rosario Caruso, Arianna Magon et al.|Seminars in Oncology|2025Cited by 1
Corrigendum to “Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 204 (2024) 104527]Silvia Belloni, Cristina Arrigoni, Alberto Zambelli et al.|Critical Reviews in Oncology/Hematology|2024Cited by 0